Will those exposed receive any immediate benefits from taking potassium iodide pills now?

Article

In response to the radiation spreading from the No. 3 reactor of the Fukushima Daiichi nuclear complex in Japan, sales of potassium iodide have soared. Some have claimed, however, that the short-term benefits of the drug are a myth, as the radioiodine is less likely to be inhaled, and more likely to be ingested in the future, often from drinking milk produced from cows grazing in areas affected by radiation fallout.

In response to the radiation spreading from the No. 3 reactor of the Fukushima Daiichi nuclear complex in Japan, sales of potassium iodide have soared. Some have claimed, however, that the short-term benefits of the drug are a myth, as the radioiodine is less likely to be inhaled, and more likely to be ingested in the future, often from drinking milk produced from cows grazing in areas affected by radiation fallout.

 

Recent Videos
Findings may help providers and patients with head and neck cancer consider whether to proceed with radiotherapy modalities, such as proton therapy or IMRT.
Study results appear to affirm anecdotal information from patients with head and neck cancer related to taste changes during and after radiotherapy.
Noah S. Kalman, MD, MBA, describes the rationale for using a test to measure granular details of taste change in patients undergoing radiotherapy for HNC.
The use of a single-port robot may allow for surgically treating more patients with head and neck cancer in a more timely manner, according to Hilary McCrary, MD, MPH.
Treatment with toripalimab does not yield the same vascular toxicity seen with pembrolizumab in patients with advanced or metastatic nasopharyngeal carcinoma, according to Barbara Burtness, MD.
Overall survival also appears to improve with toripalimab compared with chemotherapy among patients with metastatic or advanced nasopharyngeal carcinoma.
Related Content